Cardiology

Cardiac Wire’s Top 8 Takeaways from ACC 2023

ACC 2023 is officially a wrap. We hope you had a blast if you made it, and had a great weekend if you stayed home. We also hope you enjoy our recap of cardiology’s biggest event in three years. Here’s Cardiac Wire’s top eight takeaways from ACC 2023:

  • Crowds & Conversations – Helped by some NOLA mojo and post-COVID vibes, ACC’s attendance (estimated by some at 20k) and overall energy surpassed most expectations.
  • Chronic Trends – Starting at the keynote and continuing throughout the conference, the rising prevalence of cardiovascular disease and major CVD risk factors dominated conversations.
  • The Guidelines Gap – If you had “treat to guidelines” on your ACC bingo card you’d be in a good spot, because the exhibit hall and sessions were full of conversations about the challenges achieving guidelines adherence.
  • The Diagnosis Gap – The same conversations often revealed massive estimates of how many more people would have qualified for those guidelines if they weren’t living undiagnosed.
  • Treatment Expansion – The continued expansion of available preventative treatments (plus new indications added to existing treatments) remains a major theme, even if many of these treatments were the focus of the fiercest debates.
  • Consumer Confidence – Healthcare insiders aren’t always quick to endorse technologies from outside of their domains, but ACC revealed a surprising acceptance of consumer products (e.g. the Apple Watch) and the overall benefits of home-based monitoring and care.
  • AI at ACC – Artificial intelligence played a much greater role at this year’s ACC, with what seemed like far more AI studies and twice as many AI vendors and AI applications in the exhibit hall.
  • Cardiologists in Demand – If you’re wondering about the state of cardiologist staffing levels, one look at all the health system and staffing company booths at ACC would have told you everything you need to know.

The Takeaway

Cardiology faces plenty of challenges, but it’s populated by some of the smartest and most passionate people in medicine who are working hard to solve those challenges (even if they don’t always agree on the solutions). Hats off to the ACC team for getting all those smart people together to push those solutions forward.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Surgeries & Interventions December 11, 2025

CAD and Treating it With PCI has No Impact on TAVR December 11, 2025

New post-hoc results from SCOPE I suggest that patients who have obstructive coronary artery disease as well as symptomatic severe aortic stenosis have similar outcomes to patients without CAD three years after TAVR. The study also suggests performing PCI in parallel to TAVR provides no benefit to these patients. But does the presence of CAD […]

Cardiac Imaging May 4, 2000

CathWorks FFRangio Goes Beyond Physiology May 4, 2000

Despite society guidelines and extensive clinical evidence demonstrating that traditional wire-based coronary physiology improves outcomes and reduces costs compared to angiography alone1-2, physiology continues to be disappointingly underutilized globally due to the inconvenience and time it adds to the procedure. The novel CathWorks FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic […]

Obesity Care December 8, 2025

Childhood Obesity CHD Risks Might Be Reversible December 8, 2025

Childhood obesity’s cardiovascular consequences might be reversible with timely intervention, after a Swedish study demonstrated that children who were overweight but achieved normal weight by young adulthood had similar coronary heart disease risk to their “never-overweight” peers. The BMI Epidemiology Study analysis linked health records to nationwide registries for 103k people in Sweden to track […]